Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis

Journal of Neuro-Oncology

Volumn 86, Issue 3, 2008, Pages 273-283

  Chan, David Y L ^a   Chen, George G ^a   Poon, Wai S ^a   Liu, Pi C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Glioblastoma; Lovastatin; Tumor necrosis factor (TNF) related apoptosis inducing ligand (TRAIL)

Indexed keywords

MEVINOLIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL ASSAY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SYNCHRONIZATION; CELL VIABILITY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; GLIOBLASTOMA; HEART DISEASE; HUMAN; HUMAN TISSUE; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; LOVASTATIN; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TETRAZOLIUM SALTS; THIAZOLES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 38049034969     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9475-3     Document Type: Article

References (35)

1. Grossman SA, Batara JF (2004) Current management of glioblastoma multiforme. Semin Oncol 31:635-644
2. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-123
3. Reardon DA, Wen PY (2006) Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents. Oncologist 11:152-164
4. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
5. Ashkenazi A, Dixit VM (1998) Death receptors: Signaling and modulation. Science 281:1305-1308
6. Kimberley FC, Screaton GR (2004) Following a TRAIL: Update on a ligand and its five receptors. Cell Res 14:359-372
7. Kato S, Shirato K, Imaizumi K, Toyota H, Mizuguchi J, Odawara M, Che XF, Akiyama S, Abe A, Tomoda A (2006) Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep 15:843-848
8. Mirandola P, Sponzilli I, Gobbi G, Marmiroli S, Rinaldi L, Binazzi R, Piccari GG, Ramazzotti G, Gaboardi GC, Cocco L, Vitale M (2006) Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. Int J Oncol 28:127-133
9. Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319:24-33
10. Ness GC, Zhao Z, Lopez D (1996) Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. Arch Biochem Biophys 325:242-248
11. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425-430
12. Chan KK, Oza AM, Siu LL (2003) The statins as anticancer agents. Clin Cancer Res 9:10-19
13. Holstein SA, Hohl RJ (2001) Synergistic interaction of lovastatin and paclitaxel in human cancer cells. Mol Cancer Ther 1:141-149
14. Werner M, Sacher J, Hohenegger M (2004) Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol 143:715-724
15. Knapp AC, Huang J, Starling G, Kiener PA (2000) Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis 152:217-227
16. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
17. Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415-1430
18. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A (2000) Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A 97:1754-1759
19. Chen GG, Sin FL, Leung BC, Ng HK, Poon WS (2005) Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death. J Cell Physiol 203:127-132
20. Chen GG, Sin FL, Leung BC, Ng HK, Poon WS (2005) Differential role of hydrogen peroxide and staurosporine in induction of cell death in glioblastoma cells lacking DNA-dependent protein kinase. Apoptosis 10:185-192
21. Allalunis-Turner MJ, Barron GM, Day RS III, Dobler KD, Mirzayans R (1993) Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134:349-354
22. Kelley TW, Tubbs RR, Prayson RA (2005) Molecular diagnostic techniques for the clinical evaluation of gliomas. Diagn Mol Pathol 14:1-8
23. Rich JN, Bigner DD (2004) Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3:430-446
24. Cafforio P, Dammacco F, Gernone A, Silvestris F (2005) Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 26:883-891
25. Shibata MA, Ito Y, Morimoto J, Otsuki Y (2004) Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: A p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 25:1887-1898
26. Chapman-Shimshoni D, Yuklea M, Radnay J, Shapiro H, Lishner M (2003) Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Exp Hematol 31:779-783
27. Janosi J, Sebestyen A, Bocsi J, Barna G, Nagy K, Valyi-Nagy I, Kopper L (2004) Mevastatin induced apoptosis in U266 human myeloma cell line. Magy Onkol 48:333-337
28. Jin Z, Dicker DT, El Deiry WS (2002) Enhanced sensitivity of G1 arrested human cancer cells suggests a novel therapeutic strategy using a combination of simvastatin and TRAIL. Cell Cycle 1:82-89
29. Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC (2000) Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res 20:2761-2771
30. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM (2004) Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem 89:168-178
31. Rattan R, Giri S, Singh AK, Singh I (2003) Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: Negative regulation of IKKalpha. Free Radic Biol Med 35:1037-1050
32. Schmidt F, Groscurth P, Kermer M, Dichgans J, Weller M (2001) Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells. Acta Neuropathol 101:217-224
33. Bouralexis S, Findlay DM, Evdokiou A (2005) Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis 10:35-51
34. Janosi J, Sebestyen A, Bocsi J, Barna G, Nagy K, Valyi-Nagy I, Kopper L (2004) Mevastatin-induced apoptosis and growth suppression in U266 myeloma cells. Anticancer Res 24:1817-1822
35. Knight MJ, Riffkin CD, Ekert PG, Ashley DM, Hawkins CJ (2004) Caspase-8 levels affect necessity for mitochondrial amplification in death ligand-induced glioma cell apoptosis. Mol Carcinog 39:173-182